See the source article by following the link below:
Scientists for the first time used CRISPR gene editing to halt the progression of Duchenne muscular dystrophy (DMD) in dogs. It is seen as a major step toward a clinical trial, as published in Science.
Scientists for the first time used CRISPR gene editing to halt the progression of Duchenne muscular dystrophy (DMD) in dogs. It is seen as a major step toward a clinical trial, as published in Science.
No comments:
Post a Comment